Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
Research ArticleArticle

CARDIOVASCULAR AND RESPIRATORY EFFECTS OF SERPASIL, A NEW CRYSTALLINE ALKALOID FROM RAUWOLFIA SERPENTINA BENTH, IN THE DOG

J. H. Trapold, A. J. Plummer and F. F. Yonkman
Journal of Pharmacology and Experimental Therapeutics February 1954, 110 (2) 205-214;
J. H. Trapold
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
A. J. Plummer
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
F. F. Yonkman
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

The cardiovascular and respiratory effects of Serpasil, a crystalline alkaloid obtained from Rauwolfia serpentina Benth, have been studied in the dog. Following the intravenous injection of Serpasil in a single dose of 0.5 to 1.0 mgm./kgm., a gradual persistent blood pressure and respiratory depression occurs in barbitalized dogs. A significant fall in blood pressure did not occur in five unanesthetized dogs following Serpasil administration.

The hypotension produced by Serpasil is initially due to vascular relaxation. However, this hypotension ultimately appears to be due to the antagonism by Serpasil of vasomotor reflexes necessary to compensate for a gradual progressive reduction in cardiac output which follows the administration of either Serpasil or its vehicle.

The occurrence of an increase in the A-V oxygen difference of venous origin without a concomitant significant increase in oxygen consumption is additional evidence of a vascular relaxation after the administration of Serpasil.

Although Serpasil produces a significant depression of the respiratory rate and volume of anesthetized dogs, arterial oxygen is not reduced to hypoxic levels.

Evidence indicating a central site of activity for Serpasil has been cited, confirmed and extended. The postulation has been presented and discussed that Serpasil produces a central inhibition of the sympathetic nervous system, possibly through specific hypothalamic depression.

Suggestions pertinent to the clinical use of Serpasil have been discussed.

Footnotes

    • Received September 15, 1953.

JPET articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Journal of Pharmacology and Experimental Therapeutics
Vol. 110, Issue 2
1 Feb 1954
  • Table of Contents
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
CARDIOVASCULAR AND RESPIRATORY EFFECTS OF SERPASIL, A NEW CRYSTALLINE ALKALOID FROM RAUWOLFIA SERPENTINA BENTH, IN THE DOG
(Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
(Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

CARDIOVASCULAR AND RESPIRATORY EFFECTS OF SERPASIL, A NEW CRYSTALLINE ALKALOID FROM RAUWOLFIA SERPENTINA BENTH, IN THE DOG

J. H. Trapold, A. J. Plummer and F. F. Yonkman
Journal of Pharmacology and Experimental Therapeutics February 1, 1954, 110 (2) 205-214;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

CARDIOVASCULAR AND RESPIRATORY EFFECTS OF SERPASIL, A NEW CRYSTALLINE ALKALOID FROM RAUWOLFIA SERPENTINA BENTH, IN THE DOG

J. H. Trapold, A. J. Plummer and F. F. Yonkman
Journal of Pharmacology and Experimental Therapeutics February 1, 1954, 110 (2) 205-214;
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • PST3093 Stimulates SERCA2a and Improves Cardiac Function
  • CRV431 Decreases Liver Fibrosis and Tumor Development
  • Is Hydroxylamine-Induced Cytotoxicity a Valid Marker for Hypersensitivity Reactions to Sulfamethoxazole in Human Immunodeficiency Virus-Infected Individuals?
Show more Article

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics